Radiation dose and relapse are predictors for development of second malignant solid tumors after cancer in childhood and adolescence: A population-based case-control study in the five Nordic countries

References

• Bhatia S, Sather HN, Pabustan OB, Trigg ME, Gaynon PS, Robison LL. Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. Blood 2002; 99: 4257–64
   PubMed Web of Science ®Google Scholar
• Wolden SL, Lamborn KR, Cleary SF, Tate DJ, Donaldson SS. Second cancers following pediatric Hodgkin's disease. J Clin Oncol 1998; 16: 536–44
   PubMed Web of Science ®Google Scholar
• Green DM, Hyland A, Barcos MP, Reynolds JA, Lee RJ, Hall BC, et al. Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence. J Clin Oncol 2000; 18: 1492–9
   PubMed Web of Science ®Google Scholar
• Tucker MA, Morris Jones PH, Boice JD, Jr, Robison LL, Stone BJ, Stovall M, et al. Therapeutic radiation at a young age is linked to secondary thyroid cancer. The Late Effects Study Group. Cancer Res 1991; 51: 2885–8
   PubMed Web of Science ®Google Scholar
• Corpron CA, Black CT, Ross MI, Herzog CS, Ried HL, Lally KP, et al. Melanoma as a second malignant neoplasm after childhood cancer. Am J Surg 1996; 172: 459–61
   PubMedGoogle Scholar
• Walter AW, Hancock ML, Pui CH, Hudson MM, Ochs JS, Rivera GK, et al. Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital. J Clin Oncol 1998; 16: 3761–7
   PubMed Web of Science ®Google Scholar
• Shearer P, Kapoor G, Beckwith JB, Takashima J, Breslow N, Green DM. Secondary acute myelogenous leukemia in patients previously treated for childhood renal tumors: A report from the National Wilms Tumor Study Group. J Pediatr Hematol Oncol 2001; 23: 109–11
   PubMed Web of Science ®Google Scholar
• de Vathaire F, Francois P, Hill C, Schweisguth O, Rodary C, Sarrazin D, et al. Role of radiotherapy and chemotherapy in the risk of second malignant neoplasms after cancer in childhood. Br J Cancer 1989; 59: 792–6
   PubMed Web of Science ®Google Scholar
• Hawkins MM, Wilson LM, Burton HS, Potok MH, Winter DL, Marsden HB, et al. Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Natl Cancer Inst 1996; 88: 270–8
   PubMed Web of Science ®Google Scholar
• Kony SJ, de Vathaire F, Chompret A, Shamsaldim A, Grimaud E, Raquin MA, et al. Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood. Lancet 1997; 350: 91–5
   PubMed Web of Science ®Google Scholar
• Guibout C, Adjadj E, Rubino C, Shamsaldin A, Grimaud E, Hawkins M, et al. Malignant breast tumors after radiotherapy for a first cancer during childhood. J Clin Oncol 2005; 23: 197–204
   PubMed Web of Science ®Google Scholar
• Robison LL. Methodologic issues in the study of second malignant neoplasms and pregnancy outcomes. Med Pediatr Oncol Suppl 1996; 1: 41–4
   PubMedGoogle Scholar
• Hawkins MM, Draper GJ, Kingston JE. Incidence of second primary tumours among childhood cancer survivors. Br J Cancer 1987; 56: 339–47
   PubMed Web of Science ®Google Scholar
• Westermeier T, Kaatsch P, Schoetzau A, Michaelis J. Multiple primary neoplasms in childhood: Data from the German Children's Cancer Registry. Eur J Cancer 1998; 34: 687–93
   PubMedGoogle Scholar
• Klein G, Michaelis J, Spix C, Wibbing R, Eggers G, Ritter J, et al. Second malignant neoplasms after treatment of childhood cancer. Eur J Cancer 2003; 39: 808–17
   PubMedGoogle Scholar
• Jazbec J, Ecimovic P, Jereb B. Second neoplasms after treatment of childhood cancer in Slovenia. Pediatr Blood Cancer 2004; 42: 574–81
   PubMedGoogle Scholar
• Jenkinson HC, Hawkins MM, Stiller CA, Winter DL, Marsden HB, Stevens MC. Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain. Br J Cancer 2004; 91: 1905–10
   PubMed Web of Science ®Google Scholar
• Olsen JH, Garwicz S, Hertz H, Jonmundsson G, Langmark F, Lanning M, et al. Second malignant neoplasms after cancer in childhood or adolescence. BMJ 1993; 307: 1030–6
   PubMedGoogle Scholar
• Garwicz S, Anderson H, Olsen JH, Dollner H, Hertz H, Jonmundsson G, et al. Second malignant neoplasms after cancer in childhood and adolescence: A population-based case-control study in the 5 Nordic countries. The Nordic Society for Pediatric Hematology and Oncology. The Association of the Nordic Cancer Registries. Int J Cancer 2000; 88: 672–8
   PubMed Web of Science ®Google Scholar
• Birch J, Marsden H. A classification scheme for childhood cancer. Int J Cancer 1987; 40: 620–4
   PubMed Web of Science ®Google Scholar
• World Health Organization. ICD-O International Classification of Diseases for Oncology. 1st ed. Geneva: 1976.
   Google Scholar
• Clayton D, Hills M. In: Statistical Models in Epidemiology. Oxford University Press, Oxford-New York-Tokyo 1993; 329–35
   Google Scholar
• Le Vu B, de Vathaire F, Shamsaldin A, Hawkins MM, Grimaud E, Hardiman C, et al. Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood. Int J Cancer 1998; 77: 370–7
   PubMed Web of Science ®Google Scholar
• ICRU International Commission on Radiation Units and Measurements. Dose specification for reporting external beam therapy with photons and electrons. ICRU report 29. Bethesda, MD; 1978.
   Google Scholar
• Diallo I, Lamon A, Shamsaldin A, Grimaud E, de Vathaire F, Chavaudra J. Estimation of the radiation dose delivered to any point outside the target volume per patient treated with external beam radiotherapy. Radiother Oncol 1996; 38: 269–71
   PubMed Web of Science ®Google Scholar
• Shamsaldin A, Grimaud E, Hardiman C, Diallo I, de-Vathaire F, Chavaudra J. Dose distribution throughout the body from radiotherapy for Hodgkin's disease in childhood. Radiother Oncol 1998; 49: 85–90
   PubMedGoogle Scholar
• StataCorporation. Stata Statistical Software, Release 6.0. In. Stata Corporation, College Station, TX; 1999.
   Google Scholar
• Preston, D, Lubin, J, Pierce, D, McConney, M. Epicure Statistical Software, Release 2.10. In. Hirosoft International Corporation, Seattle,WA; 1993.
   Google Scholar
• Modan B, Chetrit A, Alfandary E, Katz L. Increased risk of breast cancer after low-dose irradiation. Lancet 1989; 1: 629–31
   PubMed Web of Science ®Google Scholar
• Shore RE, Hildreth N, Dvoretsky P, Andresen E, Moseson M, Pasternack B. Thyroid cancer among persons given X-ray treatment in infancy for an enlarged thymus gland. Am J Epidemiol 1993; 137: 1068–80
   PubMedGoogle Scholar
• Lindberg S, Karlsson P, Arvidsson B, Holmberg E, Lunberg LM, Wallgren A. Cancer incidence after radiotherapy for skin haemangioma during infancy. Acta Oncol 1995; 34: 735–40
   PubMed Web of Science ®Google Scholar
• United Nations Scientific Comittee on the Effects of Atomic Radiation U. Sources and effects of ionizing radiation. New York: United Nations; 2000.
   Google Scholar
• Travis LB, Hill DA, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 2003; 290: 465–75
   PubMed Web of Science ®Google Scholar
• van Leeuwen FE, Klokman WJ, Stovall M, Dahler EC, van't Veer MB, Noordijk EM, et al. Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst 2003; 95: 971–80
   PubMed Web of Science ®Google Scholar
• Gilbert ES, Stovall M, Gospodarowicz M, Van Leeuwen FE, Andersson M, Glimelius B, et al. Lung cancer after treatment for Hodgkin's disease: Focus on radiation effects. Radiat Res 2003; 159: 161–73
   PubMed Web of Science ®Google Scholar
• Verellen D, Vanhavere F. Risk assessment of radiation-induced malignancies based on whole-body equivalent dose estimates for IMRT treatment in the head and neck region. Radiother Oncol 1999; 53: 199–203
   PubMed Web of Science ®Google Scholar
• Hall EJ, Wuu CS. Radiation-induced second cancers: The impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 2003; 56: 83–8
   PubMed Web of Science ®Google Scholar
• Dorr W, Herrmann T. Cancer induction by radiotherapy: Dose dependence and spatial relationship to irradiated volume. J Radiol Prot 2002; 22: 117–21
   PubMedGoogle Scholar
• Clemons M, Loijens L, Goss P. Breast cancer risk following irradiation for Hodgkin's disease. Cancer Treat Rev 2000; 26: 291–302
   PubMed Web of Science ®Google Scholar
• Robison LL. Survivors of childhood cancer and risk of a second tumor [editorial; comment]. J Natl Cancer Inst 1993; 85: 1102–3
   PubMedGoogle Scholar
• Neglia JP, Friedman DL, Yasui Y, Mertens AC, Hammond S, Stovall M, et al. Second malignant neoplasms in five-year survivors of childhood cancer: Childhood cancer survivor study. J Natl Cancer Inst 2001; 93: 618–29
   PubMed Web of Science ®Google Scholar
• Beaty O 3rd, Hudson MM, Greenwald C, Luo X, Fang L, Wilimas JA, et al. Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol 1995; 13: 603–9
   PubMed Web of Science ®Google Scholar
• Jenkin D, Greenberg M, Fitzgerald A. Second malignant tumours in childhood Hodgkin's disease. Med Pediatr Oncol 1996; 26: 373–9
   PubMedGoogle Scholar
• van Leeuwen FE, Klokman WJ, Veer MB, Hagenbeek A, Krol AD, Vetter UA, et al. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 2000; 18: 487–97
   PubMed Web of Science ®Google Scholar
• Tarbell NJ, Gelber RD, Weinstein HJ, Mauch P. Sex differences in risk of second malignant tumours after Hodgkin's disease in childhood. Lancet 1993; 341: 1428–32
   PubMed Web of Science ®Google Scholar
• Nachman JB, Sposto R, Herzog P, Gilchrist GS, Wolden SL, Thomson J, et al. Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy. J Clin Oncol 2002; 20: 3765–71
   PubMed Web of Science ®Google Scholar